Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Open-label, add-on trial of cetirizine for neuromyelitis optica.

Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin FD.

Neurol Neuroimmunol Neuroinflamm. 2018 Feb 2;5(2):e441. doi: 10.1212/NXI.0000000000000441. eCollection 2018 Mar.

2.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

3.

Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.

Sperling R, Kraus TA, Ding J, Veretennikova A, Lorde-Rollins E, Singh T, Lo Y, Quayle AJ, Chang TL.

J Reprod Immunol. 2013 Sep;99(1-2):80-7. doi: 10.1016/j.jri.2013.07.003. Epub 2013 Aug 8.

4.

Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Gardner TJ, Bolovan-Fritts C, Teng MW, Redmann V, Kraus TA, Sperling R, Moran T, Britt W, Weinberger LS, Tortorella D.

Clin Vaccine Immunol. 2013 Apr;20(4):540-50. doi: 10.1128/CVI.00644-12. Epub 2013 Feb 6.

5.

Localized mucosal response to intranasal live attenuated influenza vaccine in adults.

Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.

J Infect Dis. 2013 Jan 1;207(1):115-24. doi: 10.1093/infdis/jis641. Epub 2012 Oct 19.

6.

Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice.

Pazos MA, Kraus TA, Muñoz-Fontela C, Moran TM.

PLoS One. 2012;7(7):e40502. doi: 10.1371/journal.pone.0040502. Epub 2012 Jul 5.

7.

The influence of pregnancy on systemic immunity.

Pazos M, Sperling RS, Moran TM, Kraus TA.

Immunol Res. 2012 Dec;54(1-3):254-61. doi: 10.1007/s12026-012-8303-9. Review.

PMID:
22447351
8.

Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum.

Sperling RS, Engel SM, Wallenstein S, Kraus TA, Garrido J, Singh T, Kellerman L, Moran TM.

Obstet Gynecol. 2012 Mar;119(3):631-9. doi: 10.1097/AOG.0b013e318244ed20.

9.

Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study.

Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, Escribese MM, Garrido JL, Singh T, Loubeau M, Moran TM.

J Clin Immunol. 2012 Apr;32(2):300-11. doi: 10.1007/s10875-011-9627-2. Epub 2011 Dec 24.

PMID:
22198680
10.

Peripheral blood cytokine profiling during pregnancy and post-partum periods.

Kraus TA, Sperling RS, Engel SM, Lo Y, Kellerman L, Singh T, Loubeau M, Ge Y, Garrido JL, Rodríguez-García M, Moran TM.

Am J Reprod Immunol. 2010 Dec;64(6):411-26. doi: 10.1111/j.1600-0897.2010.00889.x. Epub 2010 Aug 16.

PMID:
20712812
11.

Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection.

Kraus TA, Garza L, Horvath CM.

Virology. 2008 Feb 5;371(1):196-205. Epub 2007 Oct 26.

12.

Morphology and anatomy of shoot, root, and propagation systems in Hoffmannseggia glauca.

Kraus TA, Grosso MA, Basconsuelo SC, Bianco CA, Malpassi RN.

Plant Biol (Stuttg). 2007 Nov;9(6):705-12. Epub 2007 May 31.

PMID:
17538863
13.

A novel role for viral-defective interfering particles in enhancing dendritic cell maturation.

Yount JS, Kraus TA, Horvath CM, Moran TM, López CB.

J Immunol. 2006 Oct 1;177(7):4503-13.

14.

Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease.

Kraus TA, Cheifetz A, Toy L, Meddings JB, Mayer L.

Inflamm Bowel Dis. 2006 Feb;12(2):82-8; discussion 81.

PMID:
16432371
15.

Oral tolerance and inflammatory bowel disease.

Kraus TA, Mayer L.

Curr Opin Gastroenterol. 2005 Nov;21(6):692-6. Review.

PMID:
16220047
16.

Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops.

Kraus TA, Brimnes J, Muong C, Liu JH, Moran TM, Tappenden KA, Boros P, Mayer L.

J Clin Invest. 2005 Aug;115(8):2234-43. Epub 2005 Jul 21.

17.

Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk.

Kraus TA, Toy L, Chan L, Childs J, Cheifetz A, Mayer L.

Ann N Y Acad Sci. 2004 Dec;1029:225-38.

PMID:
15681761
18.

Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease.

Kraus TA, Toy L, Chan L, Childs J, Mayer L.

Gastroenterology. 2004 Jun;126(7):1771-8.

PMID:
15188172
19.

A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.

Kraus TA, Lau JF, Parisien JP, Horvath CM.

J Biol Chem. 2003 Apr 11;278(15):13033-8. Epub 2003 Feb 5.

21.

High levels of CD44 expression distinguish virgin from antigen-primed B cells.

Camp RL, Kraus TA, Birkeland ML, Puré E.

J Exp Med. 1991 Mar 1;173(3):763-6.

22.

Supplemental Content

Loading ...
Support Center